He is a third-generation businessman who has specialisation in chemical and pharmaceutical sciences from the University of Sunderland, UK.
Sharvil Patel, son of Indian pharma billionaire Pankaj Patel, is the Managing Director of Zydus Lifesciences Ltd, a multinational pharmaceutical company. He has been the company's managing director since July 2017. Before this, he was serving as the joint managing director of Zydus. He is the only son of Pankaj Patel, who is the chairman of Zydus.
Sharvil is a third-generation businessman. The company has a market capitalisation of Rs 63,394 crore as of September 12, 2023. The per-piece share price of the pharma company was Rs 626.30 on Tuesday. The company (formerly Cadila Healthcare) was co-founded by his late grandfather in 1952 to make vitamins.
Sharvil completed his specialisation in chemical and pharmaceutical sciences from the University of Sunderland, UK. He also holds a doctorate from the same university for his research work in Breast Cancer at John Hopkins Medical Centre, US. He combines both pharma and research expertise.
His father Pankaj Patel is a pharma magnate who has a real-time net worth of around Rs 51,390 crore (on September 12), according to Forbes. Pankaj joined the firm in 1976 and took charge in 1995 after a formal separation between the two founding families.
Zydus manufactures Covid-19 vaccine, ZyCoV-D. It also manufactures drugs to treat Covid-19 such as Remdesivir from Gilead. The company makes active pharmaceutical ingredients at four sites in India, Ankleshwar plants, Vadodara plant, and Ahmedabad plant.
READ | Meet the woman CEO who runs Rs 51,382 crore pharma company with brother
ncG1vNJzZmivp6x7pbrAoqWdoZFjsLC5jpusrKGemsC0e9Gep6iqpGK6orqMsJ%2BoZZyarqW%2FjKuqZm5jaIZ1ecKrpqudXZi8rrzAp7Bmq5%2BjerCyjKmfmqqdlnqjtculoKimkZ6%2FpnnWoquhZaKoenZ9knJnZpuiYrumwIywpqusmGLAqa3Rr6ClZaCWwaa4jLOwna2jYoBxgo9rbnA%3D